Project Grant K99HL175100
Award Date
8/15/24
Completion Date
6/30/26
Dollars Obligated
$136K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30302, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $165,364 to The Broad Institute, Inc. to conduct research focused on integrating novel contextual and genomic blood pressure measures to enhance cardiovascular disease prediction and management in young adults aged 18-39 years. The key objectives of this 2-year project are to: 1) identify novel ambulatory blood pressure patterns that capture dynamic responses to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $717,236 to The University of Iowa to study the role of neuronal primary cilia in hypertension, autonomic dysfunction, and body fluid imbalance. The goal is to evaluate how conditional ablation of cilia in the supraoptic nucleus affects blood pressure, drinking, urine volume, sodium concentration, plasma osmolality, regional sympathetic...
The federal Project Grant award R01HL176882, totaling $734,722.00, was provided by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to the University of Alabama at Birmingham (UAB). The award will fund a randomized clinical trial to assess the efficacy of disseminating systolic blood pressure polygenic risk scores (SBP PRS) on SBP control, adherence to a healthy lifestyle, and cardiometabolic profile among 300 hypertensive young and middle-aged U.S....
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $644,687 to the University of Missouri System to conduct research on a neural circuit in the brain that contributes to hypertension associated with obstructive sleep apnea. The research aims to determine how this "orexin-CRH-NTS" circuit facilitates the peripheral chemoreflex and leads to sympathoexcitation and hypertension,...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $2,042,978 to the University of South Alabama to investigate the molecular mechanisms by which the protein progranulin regulates endothelial function and blood pressure control. The key objectives are to determine how reduced endothelial progranulin levels contribute to the development and progression of hypertension through...
This federal Project Grant award, totaling $2,158,428 and funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research aimed at investigating the role of the glycolytic enzyme pyruvate kinase M2 (PKM2) in mediating hypertension and vascular remodeling. The award supports three specific aims: 1) Studying the involvement of PKM2 activation in vascular smooth muscle cells (VSMCs) in hypertension and vascular...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Federal Grant Program CFDA 93.837 - Cardiovascular Diseases Research, provides $249,000.00 in funding to Texas A&M University System Health Science Center to conduct research on the regulation of vasopressin neurons in a rodent model of heart failure. The key goals of the research are to investigate how vasopressin neurons self-regulate their excitability and paracrine release of vasopressin, and...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $114,180.00 to the Regents of the University of Minnesota to conduct research on renal afferent nerve circuitry and its influence on blood pressure regulation. The project aims to 1) elucidate the central terminations and regional specificity of renal afferents, and 2) identify...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $213,314 to The University of Iowa to investigate the molecular mechanisms underlying aldosterone-mediated sodium appetite. The research aims to: 1) determine the importance of aldosterone/mineralocorticoid receptor signaling in specific neurons for sodium appetite, 2) identify aldosterone-regulated genes in these neurons that could...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,092,000 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to The Medical College of Wisconsin, Inc. to conduct research on the intersection of the PPARG-RHOBTB1-CULLIN-3 pathway and the renin-angiotensin system, and their role in blood pressure regulation, vascular function, and arterial stiffness. The 7-year project aims to elucidate the molecular and physiological mechanisms controlling vasomotor function, arterial...